Angiogenic Hydrogels to Accelerate Early Wound Healing
Authors:
- 22 May 2022
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 22 (7) , e2200067
Abstract
Diabetes mellitus affects an increasing proportion of the population, and is projected to double by 2060. Comorbidities contribute to an interrupted healing process which is delayed, prolonged, and associated with increased susceptibility to infection and unresolved inflammation. This leads to chronic nonhealing wounds and potential amputation. Here, the use of a bioactive angiogenic peptide‐based hydrogel, SLan, is examined to improve early wound healing in diabetic rats, and its performance is compared to clinically utilized biosynthetic peptide‐based materials such as Puramatrix. Streptozotocin‐treated diabetic rats underwent 8 mm biopsy wounding in their dorsum. Wounds are treated with either Low (1 w%) SLan, High (4 w%) SLan, phosphate buffered saline (PBS), Puramatrix, or K2 (an unfunctionalized nonbioactive control sequentially similar to SLan), covered with Tegaderm, and monitored on for a month; animals are sacrificed for histomorphic analyses and immunostaining. Pharmacokinetic analysis showing no trafficking of peptides from the wound into the circulation. SLan groups show similar wound contraction as control groups (Puramatrix, PBS, and K2), however, showing marked improvement in healing in earlier time points, including increased deposition of new mature blood vessels. Altogether the results suggest this material can be used to “jumpstart” the diabetic wound healing process.Keywords
Funding Information
- National Science Foundation (1903617)
- National Eye Institute (R15 EY029504)
This publication has 71 references indexed in Scilit:
- Treatment of Mouse Limb Ischemia with an Integrative Hypoxia-Responsive Vector Expressing the Vascular Endothelial Growth Factor GenePLOS ONE, 2012
- Vascular Endothelial Growth Factor-Delivery Systems for Cardiac Repair: An OverviewTheranostics, 2012
- Design properties of hydrogel tissue-engineering scaffoldsExpert Review of Medical Devices, 2011
- Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsJournal of The Royal Society Interface, 2010
- Wound Healing in Mice with High-Fat Diet- orobGene-Induced Diabetes-Obesity Syndromes: A Comparative StudyExperimental Diabetes Research, 2010
- Sustained Release of Multiple Growth Factors from Injectable Polymeric System as a Novel Therapeutic Approach Towards AngiogenesisPharmaceutical Research, 2009
- VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN TrialMolecular Therapy, 2009
- Cellular and molecular basis of wound healing in diabetesJournal of Clinical Investigation, 2007
- Peripheral Arterial Disease in Patients With DiabetesJACC, 2006
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989